selected publications
- Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma. Blood advances. 2023 Academic Article GET IT
- Do no harm: Distinguishing between rebound thymic hyperplasia and Hodgkin lymphoma relapse in children. Pediatric blood & cancer. 2023 Academic Article GET IT
- Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells. Blood cancer discovery. 2023 Academic Article GET IT
- Does congenital cytomegalovirus infection contribute to the development of acute lymphoblastic leukemia in children?. Current opinion in virology. 2023 Review GET IT
- Primary Mediastinal B-Cell Lymphoma in Children and Young Adults. Journal of the National Comprehensive Cancer Network : JNCCN. 2023 Review GET IT
- Diagnosis and management of Hodgkin lymphoma in children, adolescents, and young adults. Best practice & research. Clinical haematology. 2023 Review GET IT
-
Methionine metabolism controls the B cell EBV epigenome and viral latency.
Cell metabolism.
2022
Academic Article
GET IT
Times cited: 5 - Author Correction: DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression. Nature microbiology. 2022 Article GET IT
-
A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome.
Blood advances.
2022
Academic Article
GET IT
Times cited: 5 - The ABVD's of cooperative trials in pediatric Hodgkin lymphoma: The India experience. Leukemia & lymphoma. 2022 Comment GET IT
-
A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma.
HemaSphere.
2021
Academic Article
GET IT
Times cited: 3 -
Therapeutic options for CTLA-4 insufficiency.
The Journal of allergy and clinical immunology.
2021
Academic Article
GET IT
Times cited: 40 -
Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group.
Blood.
2021
Academic Article
GET IT
Times cited: 12 - AYA Considerations for Aggressive Lymphomas. Current hematologic malignancy reports. 2021 Review GET IT
-
Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes.
Blood advances.
2020
Academic Article
GET IT
Times cited: 20 -
Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy.
Blood.
2020
Academic Article
GET IT
Times cited: 31 -
DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression.
Nature microbiology.
2020
Academic Article
GET IT
Times cited: 19 -
MYC Controls the Epstein-Barr Virus Lytic Switch.
Molecular cell.
2020
Academic Article
GET IT
Times cited: 42 -
Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents.
Blood advances.
2019
Academic Article
GET IT
Times cited: 17 -
Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2019
Academic Article
GET IT
Times cited: 84 - Otolaryngologist and pediatric oncologist perspectives on the role of fine needle aspiration in diagnosing pediatric head and neck masses. International journal of pediatric otorhinolaryngology. 2019 Academic Article GET IT
-
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model.
Oncoimmunology.
2018
Academic Article
GET IT
Times cited: 13 -
Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers.
Frontiers in immunology.
2018
Academic Article
GET IT
Times cited: 57 -
How I treat primary mediastinal B-cell lymphoma.
Blood.
2018
Review
GET IT
Times cited: 44 -
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.
The Journal of allergy and clinical immunology.
2018
Academic Article
GET IT
Times cited: 264 -
Enhancer of zeste homolog 2 (EZH2) inhibitors.
Leukemia & lymphoma.
2018
Review
GET IT
Times cited: 114 -
Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience.
Leukemia & lymphoma.
2017
Academic Article
GET IT
Times cited: 8 -
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.
British journal of haematology.
2017
Academic Article
GET IT
Times cited: 91 -
Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.
Molecular cancer therapeutics.
2017
Academic Article
GET IT
Times cited: 47 -
CD4-Negative Variant of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm With a Novel PBRM1 Mutation in an 11-Year-Old Girl.
2017
GET IT
Times cited: 5 -
Management of primary central nervous system lymphoma in children.
Hematology. American Society of Hematology. Education Program.
2016
Review
GET IT
Times cited: 7 -
Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.
British journal of haematology.
2016
Review
GET IT
Times cited: 15 - Reducing radiation exposure in children with febrile neutropenia: can pulmonary MRI replace CT?. Leukemia & lymphoma. 2015 Comment GET IT
-
Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents.
British journal of haematology.
2015
Review
GET IT
Times cited: 17 -
EZH2: a potential new target in T-cell lymphoma?.
Leukemia & lymphoma.
2015
Comment
GET IT
Times cited: 4 -
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.
Blood.
2014
Academic Article
GET IT
Times cited: 237 -
Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.
Pediatric blood & cancer.
2013
Academic Article
GET IT
Times cited: 30 -
Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report.
British journal of haematology.
2013
Academic Article
GET IT
Times cited: 27 -
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes.
Blood.
2012
Academic Article
GET IT
Times cited: 82 -
Sweet syndrome in patients with Fanconi anaemia: association with extracutaneous manifestations and progression of haematological disease.
British journal of haematology.
2011
Letter
GET IT
Times cited: 8 -
A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.
Blood.
2011
Academic Article
GET IT
Times cited: 28 -
Treatment with rituximab in benign and malignant hematologic disorders in children.
The Journal of pediatrics.
2007
Review
GET IT
Times cited: 57 -
Update on therapeutic monoclonal antibodies.
Current problems in pediatric and adolescent health care.
2007
Review
GET IT
Times cited: 10 -
Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes.
American journal of obstetrics and gynecology.
2006
Academic Article
GET IT
Times cited: 62 -
Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection?.
Journal of child and adolescent psychopharmacology.
2002
Academic Article
GET IT
Times cited: 32